We are live on ! Find out more
BC

Bartlett & Co Portfolio holdings

AUM $6.16B
1-Year Est. Return 20.29%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
10 Year Est. Return
AUM
$5.78B
AUM Growth
+$604M
Cap. Flow
+$315M
Cap. Flow %
5.44%
Top 10 Hldgs %
30.92%
Holding
1,221
New
145
Increased
296
Reduced
158
Closed
48

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$21.8M
2
AAPL icon
Apple
AAPL
+$17.5M
3
UNH icon
UnitedHealth
UNH
+$13.1M
4
TMO icon
Thermo Fisher Scientific
TMO
+$12.6M
5
CFR icon
Cullen/Frost Bankers
CFR
+$12.2M

Sector Composition

Rank Sector Weight
1 Technology 19.66%
2 Miscellaneous 17.21%
3 Healthcare 12.66%
4 Financials 11.11%
5 Industrials 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FITB
251
Fifth Third Bancorp
FITB
$49B
$1.18M 0.02%
44,418
-51
-0.1% -$1.31K
BAC.PRN icon
252
Bank of America Depository Shares Series LL
BAC.PRN
$981M
$1.18M 0.02%
54,109
-375
-0.7% -$8.17K
NRG icon
253
NRG Energy
NRG
$24.4B
$1.18M 0.02%
+31,485
New +$1.07M
IEX icon
254
IDEX
IEX
$16.6B
$1.16M 0.02%
5,400
-250
-4% -$52.6K
CAT icon
255
Caterpillar
CAT
$376B
$1.16M 0.02%
4,700
+2,167
+86% +$483K
MDT icon
256
Medtronic
MDT
$118B
$1.14M 0.02%
12,796
+2,015
+19% +$173K
ISRG icon
257
Intuitive Surgical
ISRG
$124B
$1.13M 0.02%
3,298
VT icon
258
Vanguard Total World Stock ETF
VT
$81.6B
$1.13M 0.02%
11,596
-515
-4% -$48.3K
MET icon
259
MetLife
MET
$60.6B
$1.12M 0.02%
19,780
+19,160
+3,090% +$1.06M
ALL icon
260
Allstate
ALL
$64.1B
$1.1M 0.02%
10,045
GS icon
261
Goldman Sachs
GS
$301B
$1.09M 0.02%
3,377
+2,065
+157% +$679K
COR icon
262
Cencora
COR
$62.1B
$1.07M 0.02%
5,551
+5,265
+1,841% +$911K
WFC icon
263
Wells Fargo
WFC
$271B
$1.06M 0.02%
24,905
-100
-0.4% -$4.03K
VCR icon
264
Vanguard Consumer Discretionary ETF
VCR
$5.84B
$1.05M 0.02%
3,691
OTIS icon
265
Otis Worldwide
OTIS
$26.3B
$1.04M 0.02%
11,744
-314
-3% -$26.5K
HSY icon
266
Hershey
HSY
$34.5B
$1.01M 0.02%
4,063
+300
+8% +$78.7K
USA icon
267
Liberty All-Star Equity Fund
USA
$1.82B
$1.01M 0.02%
156,558
+156,000
+27,957% +$953K
AMAT icon
268
Applied Materials
AMAT
$372B
$1M 0.02%
6,925
+5,775
+502% +$723K
CMG icon
269
Chipotle Mexican Grill
CMG
$45.9B
$999K 0.02%
23,350
PFF icon
270
iShares Preferred and Income Securities ETF
PFF
$12.9B
$982K 0.02%
31,747
+1,285
+4% +$39.3K
SCHD icon
271
Schwab US Dividend Equity ETF
SCHD
$110B
$975K 0.02%
40,266
+4,899
+14% +$117K
LSXMK
272
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$964K 0.02%
38,025
AWK icon
273
American Water Works
AWK
$27.9B
$962K 0.02%
6,737
+675
+11% +$99.1K
LXP icon
274
LXP Industrial Trust
LXP
$3.58B
$959K 0.02%
+19,432
New +$960K
BNY
275
Bank of New York Mellon
BNY
$111B
$954K 0.02%
21,419
+2,000
+10% +$85.8K

Similar funds

Bartlett & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Bartlett & Co held 1,221 positions worth $5.78B, up 12% from $5.18B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bartlett & Co deployed $315M of net new capital in Q2 2023, opening 145 new positions and adding to 296 existing holdings. Its largest new stake was Toro Company: 25,480 shares worth $2.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $18.1M trimmed.

  • Bartlett & Co's largest Q2 2023 buy was Toro Company: 25,480 shares worth $2.6M.
  • Bartlett & Co added most to Chevron in Q2 2023, an estimated $21.8M increase.
  • Bartlett & Co's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $18.1M.
  • Bartlett & Co fully exited iPath Pure Beta Broad Commodity ETN in Q2 2023, selling an estimated $684K.
  • Bartlett & Co's ten largest holdings make up 31% of its $5.78B portfolio in Q2 2023.
  • Bartlett & Co opened 145 new positions and closed 48 in Q2 2023.
  • Bartlett & Co's portfolio value rose 12% quarter-over-quarter to $5.78B.

Based on Bartlett & Co's 13F filing for Q2 2023, filed 14 Jul 2023.